270 related articles for article (PubMed ID: 18571239)
1. Cyanobacterial LPS antagonist (CyP)-a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig.
Thorgersen EB; Macagno A; Rossetti C; Mollnes TE
Mol Immunol; 2008 Aug; 45(13):3553-7. PubMed ID: 18571239
[TBL] [Abstract][Full Text] [Related]
2. Meconium-induced release of cytokines is mediated by the TRL4/MD-2 complex in a CD14-dependent manner.
Salvesen B; Stenvik J; Rossetti C; Saugstad OD; Espevik T; Mollnes TE
Mol Immunol; 2010 Mar; 47(6):1226-34. PubMed ID: 20092898
[TBL] [Abstract][Full Text] [Related]
3. Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood.
Brekke OL; Christiansen D; Fure H; Pharo A; Fung M; Riesenfeld J; Mollnes TE
Mol Immunol; 2008 Aug; 45(14):3804-13. PubMed ID: 18606453
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of inhibiting MD-2 and CD14 on LPS- versus whole E. coli bacteria-induced cytokine responses in human blood.
Christiansen D; Brekke OL; Stenvik J; Lambris JD; Espevik T; Mollnes TE
Adv Exp Med Biol; 2012; 946():237-51. PubMed ID: 21948372
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the ovine acute phase response and hepatic gene expression in response to Escherichia coli endotoxin.
Kabaroff LC; Rodriguez A; Quinton M; Boermans H; Karrow NA
Vet Immunol Immunopathol; 2006 Sep; 113(1-2):113-24. PubMed ID: 16806492
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast.
Ren L; Leung WK; Loo TW; Jin L
J Periodontal Res; 2005 Oct; 40(5):407-16. PubMed ID: 16105094
[TBL] [Abstract][Full Text] [Related]
8. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein.
Tsutsumi-Ishii Y; Shimada K; Daida H; Toman R; Nagaoka I
Int Immunol; 2008 Feb; 20(2):199-208. PubMed ID: 18056918
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
Liu Y; Shi J; Lu J; Meng G; Zhu H; Hou Y; Yin Y; Zhao S; Ding B
Innate Immun; 2009 Jun; 15(3):169-78. PubMed ID: 19474210
[TBL] [Abstract][Full Text] [Related]
10. Polycationic lipids inhibit the pro-inflammatory response to LPS.
Leon-Ponte M; Kirchhof MG; Sun T; Stephens T; Singh B; Sandhu S; Madrenas J
Immunol Lett; 2005 Jan; 96(1):73-83. PubMed ID: 15585310
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization.
De Smedt-Peyrusse V; Sargueil F; Moranis A; Harizi H; Mongrand S; Layé S
J Neurochem; 2008 Apr; 105(2):296-307. PubMed ID: 18021297
[TBL] [Abstract][Full Text] [Related]
12. The bovine innate immune response during experimentally-induced Pseudomonas aeruginosa mastitis.
Bannerman DD; Chockalingam A; Paape MJ; Hope JC
Vet Immunol Immunopathol; 2005 Sep; 107(3-4):201-15. PubMed ID: 15970335
[TBL] [Abstract][Full Text] [Related]
13. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
14. Effect of the lipopolysaccharide antagonist Planktothrix sp. FP1 cyanobacterial extract on human polymorphonuclear leukocytes.
Maio RC; Cosentino M; Rossetti C; Molteni M; Lecchini S; Marino F
Int Immunopharmacol; 2011 Feb; 11(2):194-8. PubMed ID: 21115122
[TBL] [Abstract][Full Text] [Related]
15. Chemokine production and pattern recognition receptor (PRR) expression in whole blood stimulated with pathogen-associated molecular patterns (PAMPs).
Møller AS; Ovstebø R; Haug KB; Joø GB; Westvik AB; Kierulf P
Cytokine; 2005 Dec; 32(6):304-15. PubMed ID: 16406558
[TBL] [Abstract][Full Text] [Related]
16. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays.
Mathiak G; Kabir K; Grass G; Keller H; Steinringer E; Minor T; Rangger C; Neville LF
Int J Mol Med; 2003 Jan; 11(1):41-4. PubMed ID: 12469215
[TBL] [Abstract][Full Text] [Related]
18. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes.
Figueiredo MD; Moore JN; Vandenplas ML; Sun WC; Murray TF
Am J Vet Res; 2008 Jun; 69(6):796-803. PubMed ID: 18518661
[TBL] [Abstract][Full Text] [Related]
19. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.
Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA
Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus and Escherichia coli cause deviating expression profiles of cytokines and lactoferrin messenger ribonucleic acid in mammary epithelial cells.
Griesbeck-Zilch B; Meyer HH; Kühn CH; Schwerin M; Wellnitz O
J Dairy Sci; 2008 Jun; 91(6):2215-24. PubMed ID: 18487644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
